Physician profile
David P Simon
NPI 1114913829
$2,295.73
in general payments reported to CMS, 2019-2025
18 companies · $556 in 2025
The $556 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $17.47 · 2021: $68.06 · 2022: $276 · 2023: $694 · 2024: $175 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360 · Entertainment: $65.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.51 |
| Entertainment | $65.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $953.59 | 2019-2025 | Clareon, Rhopressa, Simbrinza |
| Abbvie INC. | $297.03 | 2022-2025 | Durysta |
| Genentech USA, INC. | $162.52 | 2022 | |
| Rxsight INC | $149.79 | 2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Carl Zeiss Meditec, INC. | $131.56 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $106.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $79.42 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $74.49 | 2019 | |
| Optos, INC. | $65.26 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $61.88 | 2020-2025 | |
| Tarsus Pharmaceuticals, INC. | $43.40 | 2025 | Xdemvy |
| Dompe US, INC. | $33.00 | 2024-2025 | Oxervate |
| Neuronetics, INC. | $28.32 | 2023 | Neurostar Tms Therapy System |
| Bausch & Lomb Americas INC. | $24.45 | 2024 | Envista Mx60 Iol |
| Carl Zeiss Meditec USA, INC. | $23.17 | 2024 | Humphrey Hfa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $22.25 | 2024 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $19.75 | 2022 | |
| Galderma Laboratories, L.P. | $18.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.